Jump to content
RemedySpot.com

Comparison of the in vitro effects of the anti-CD20 antibodies rituximab and GA101 on chronic lymphocytic leukaemia cells.

Rate this topic


Recommended Posts

Posted

Blank Comparison of the in vitro effects of the anti-CD20 antibodies rituximab

and GA101 on chronic lymphocytic leukaemia cells.

M Patz, P Isaeva, N Forcob, B Muller, LP Frenzel, CM Wendtner, C Klein, P Umana,

M Hallek, and G Krause

Br J Haematol, December 13, 2010; .

Department I of Internal Medicine and Centre for Integrated Oncology Cologne

Excellence Cluster on Cellular Stress Responses in Aging-associated Diseases

(CECAD), University of Cologne, Cologne, Germany Roche Glycart AG, Schlieren,

Switzerland.

The effects of two CD20 antibodies, namely rituximab, the current standard for

treatment of chronic lymphocytic leukaemia (CLL) in combination with

chemotherapy, and GA101, a glyco-engineered type II antibody were compared on

CLL cells ex vivo. Antibody-induced phosphatidylserine exposure was examined in

isolated CLL cells. For a more comprehensive assessment of antibody-mediated

cell killing including Fc-mediated mechanisms, B cell depletion from whole blood

samples was monitored. Treatment with rituximab or GA101 reduced the average

viability of isolated CLL cells by 6% or 11%, and the ratio of B to T cells in

whole blood samples by 12% or 33%, respectively. Combination with GA101 enhanced

the cytotoxicity of the chemotherapeutic agent chlorambucil on isolated CLL

cells. CD20 surface expression on CLL cells correlated with GA101-induced B cell

depletion, but not with direct cell death induction. Treatment of whole blood

samples from CLL patients with a CpG-containing oligonucleotide increased CD20

expression on CLL cells and GA101-dependent B cell depletion. Despite the

variable responses of individual CLL samples, the CLL cell depletion from whole

blood by GA101 was consistently much stronger than by rituximab, which argues

for clinical investigation of GA101 in CLL patients.

PMID: 21155758

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...